MOESM2 of Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial

Additional file 2: Table B. Baseline Clinical and Laboratory Characteristics of the study cohort by triglyceride level ≥ and < 200 mg/dl

MOESM1 of Clinical impact of diabetes mellitus in patients undergoing transcatheter aortic valve replacement

Additional file 1: Table S1. Complication rates based on HbA1c levels